Overview Of Secondary Metabolites With Anticancer Potential

  • سال انتشار: 1403
  • محل انتشار: چهارمین کنگره جهانی یافته های نوین در سلامت، علوم بهداشتی و علوم تربیتی
  • کد COI اختصاصی: IEMC04_035
  • زبان مقاله: انگلیسی
  • تعداد مشاهده: 72
دانلود فایل این مقاله

نویسندگان

Nazanin Pashotan

PhD student in Microbiology, Faculty of Biological Sciences, Islamic Azad University, Falavarjan Branch, Isfahan, Iran.

Tala Hayati

PhD student in Microbiology, Faculty of Biological Sciences, Islamic Azad University, Falavarjan Branch, Isfahan, Iran.

Mehdi Molavizadeh

PhD student in Microbiology, Faculty of Biological Sciences, Islamic Azad University, Falavarjan Branch, Isfahan, Iran.

Neda Korkorian

PhD student in Microbiology, Faculty of Biological Sciences, Islamic Azad University, Falavarjan Branch, Isfahan, Iran.

چکیده

Cancer is a leading cause of mortality worldwide, despite significant advancements in its diagnosis and treatment. The development of resistance to chemotherapeutic agents, their side effects, and non-specific toxicity necessitate the screening for new anticancer agents. Therefore, the development of new anticancer agents with novel mechanisms of action has become a major scientific challenge. Recently, bacteria and the bioactive compounds produced by them have emerged as a promising alternative for cancer treatment. Bacterial anticancer agents such as antibiotics, bacteriocins, non-ribosomal peptides, polyketides, toxins, and others exhibit various mechanisms of action, including apoptosis, necrosis, reduction of angiogenesis, inhibition of translation and binding, and blocking signaling pathways essential for the elimination of cancer cells. Additionally, targeted live bacteria have provided a unique therapeutic alternative for cancer treatment. In this article, we review the anticancer properties and mechanisms of action of bacterial-derived anticancer agents and tumor-targeting bacteria, along with their potential future applications in cancer therapy.

کلیدواژه ها

Cancer, Bacteriocin, Antibiotic, Anticancer Drug, Cancer Therapy, Anticancer Bacteria

مقالات مرتبط جدید

اطلاعات بیشتر در مورد COI

COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.

کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.